Aller au contenu principal
Accès ouvert déclaré 2025 article

Facts and Misfacts on D ‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis ( SISET )

8Citations signalées — pas une note de qualité
14Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

D-dimer defines degradation products derived from the proteolysis mediated by plasmin on cross-linked fibrin. The evidence-based use of D-dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D-dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start time-consuming diagnostic procedures that may generate patient anxiety/distress and often fail to reach meaningful conclusions for patients' management. To make things worse, the incidental finding of unexplained elevated D-dimer is often, and inadvertently, taken as an index of venous thromboembolism (VTE) that may induce unnecessary initiation of thromboprophylaxis. Finally, population studies showed that elevated D-dimer is variably associated with arterial thrombosis. However, the above studies do not allow establishing a direct causal relationship between elevated D-dimer and disease, which makes D-dimer measurement hardly applicable in individual patients. With this as background, the Italian Society on Thrombosis and Hemostasis appointed a panel to prepare a guidance on the use of D-dimer based on the literature and expert opinion. The main conclusions of the panel can be summarized as follows: (i) D-dimer can be reliably used in combination with pre-test clinical probability to exclude VTE in symptomatic outpatients. (ii) It may help establish the optimal duration of secondary VTE prevention with vitamin K antagonists, although the panel felt that this area needs further investigation when dealing with direct oral anticoagulants. (iv) The use of D-dimer in combination with the pre-test probability score can be used to safely rule out acute aortic syndromes in the emergency setting without further imaging tests.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Facts and Misfacts on <scp>D</scp> ‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis ( <scp>SISET</scp> )
Date Crossref
29/09/2025
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsAtrial Fibrillation Management and Outcomes

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.